VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
RIGL
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
RIGLRigel Pharmaceuticals, Inc.
$42.56$787M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksRIGLQuarterly Financials

Rigel Pharmaceuticals, Inc. (RIGL) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Rigel Pharmaceuticals, Inc. (RIGL) quarterly income statement — complete revenue, gross profit & net income history

RIGL Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Sales/Revenue58.82M69.8M69.46M101.69M53.33M57.6M55.31M36.84M29.53M35.79M28.13M26.89M26.07M51.28M22.41M29.82M16.73M20.41M21.54M26.27M
Revenue Growth %10.28%21.19%25.59%176.01%80.58%60.92%96.58%37.03%13.29%-30.2%25.54%-9.84%55.78%151.25%4.02%13.53%-79.34%10.62%17.15%63.95%
Cost of Goods Sold4.61M5.96M4.75M4.5M4.41M5.79M8.03M2.81M2.02M3.79M1.27M1.07M977K342K250K1.04M121K487K151K129K
COGS % of Revenue7.83%8.53%6.84%4.43%8.27%10.05%14.51%7.62%6.86%10.59%4.51%4%3.75%0.67%1.12%3.47%0.72%2.39%0.7%0.49%
Gross Profit54.21M63.85M64.71M97.18M48.92M51.81M47.28M34.03M27.51M32M26.87M25.81M25.09M50.94M22.16M28.78M16.61M19.92M21.39M26.14M
Gross Margin %92.17%91.47%93.16%95.57%91.73%89.95%85.49%92.38%93.14%89.41%95.49%96%96.25%99.33%98.88%96.53%99.28%97.61%99.3%99.51%
Gross Profit Growth %10.81%23.24%36.86%185.54%77.85%61.89%75.99%31.86%9.63%-37.17%21.24%-10.33%51.04%155.68%3.59%10.12%-79.41%9.89%17.22%66.03%
Operating Expenses42.33M40.68M36.29M36.08M36.15M35.15M33.23M33.59M34.48M30.04M31.33M31.08M37.82M48.86M40.56M41.75M42.88M41.34M41.18M39.19M
OpEx % of Revenue71.96%58.27%52.24%35.48%67.78%61.03%60.07%91.17%116.73%83.92%111.36%115.59%145.06%95.28%181%140%256.2%202.56%191.14%149.19%
Selling, General & Admin30.65M29.99M28.94M29.26M27.71M29.52M27.04M28.05M28.45M26.85M24.86M26.31M27.73M32.17M25.9M26.98M27.4M24.52M22.88M22.38M
SG&A % of Revenue52.11%42.97%41.66%28.77%51.97%51.25%48.9%76.13%96.33%75.02%88.35%97.84%106.36%62.74%115.56%90.48%163.73%120.12%106.19%85.2%
Research & Development11.68M10.69M7.35M6.82M8.44M5.63M6.18M5.54M6.03M3.19M6.47M4.77M10.09M15.37M14.67M14.77M15.47M13.3M18.3M16.81M
R&D % of Revenue19.85%15.31%10.59%6.71%15.82%9.78%11.18%15.04%20.4%8.9%23.01%17.75%38.7%29.96%65.44%49.52%92.46%65.19%84.95%63.99%
Other Operating Expenses00000000000001000K0001000K00
Operating Income11.88M23.17M28.42M61.1M12.77M16.66M14.06M447K-6.97M1.97M-4.46M-5.27M-12.72M2.08M-18.4M-12.96M-26.26M-21.42M-19.79M-13.05M
Operating Margin %20.21%33.19%40.91%60.09%23.95%28.92%25.41%1.21%-23.59%5.49%-15.87%-19.59%-48.81%4.05%-82.12%-43.48%-156.92%-104.94%-91.84%-49.68%
Operating Income Growth %-6.95%39.12%102.19%13569.57%283.36%747.15%414.8%108.49%45.26%-5.44%75.74%59.38%51.54%109.71%6.99%0.64%-162.89%-13.76%-43.57%24.98%
EBITDA11.88M23.77M29.02M61.71M13.38M17.26M14.67M1.06M-6.57M2.26M-4.17M-4.97M-12.37M2.36M-18.16M-12.73M-26.02M-21.01M-19.52M-12.79M
EBITDA Margin %20.21%34.05%41.78%60.69%25.08%29.97%26.52%2.88%-22.23%6.31%-14.83%-18.49%-47.44%4.61%-81.05%-42.68%-155.51%-102.96%-90.63%-48.69%
EBITDA Growth %-11.15%37.73%97.88%5721.7%303.73%664.01%451.47%121.32%46.91%-4.4%77.02%60.94%52.47%111.24%6.97%0.48%-161.97%-12.85%-43.39%25.76%
D&A (Non-Cash Add-back)0601K603K607K604K604K611K613K400K293K292K296K357K284K240K237K237K404K261K258K
EBIT11.88M20.73M29.51M61.86M13.36M17.18M14.48M999K-6.37M2.64M-3.79M-4.74M-12.33M2.51M-18.21M-12.92M-26.24M-21.4M-19.77M-13.03M
Net Interest Income0-456K-800K-1.12M-1.26M-1.43M-1.64M-1.48M-1.28M-1.23M-1.23M-1.33M-811K-678K-634K-527K-1.18M-1.28M-1.3M-1.74M
Interest Income1.21M1.24M1.09M753K591K522K425K552K593K678K672K529K393K429K192K42K21K16K14K16K
Interest Expense-1.43M1.7M1.89M1.87M1.85M1.96M2.06M2.03M1.87M1.91M1.9M1.86M1.2M1.11M826K569K1.21M1.3M1.32M1.76M
Other Income/Expense-228K-456K-800K-1.12M-1.26M-1.43M-1.64M-1.48M-1.28M-1.23M-1.23M-1.33M-811K-678K-634K-527K-1.18M-1.28M-1.3M-1.74M
Pretax Income11.66M22.71M27.62M59.98M11.51M15.22M12.42M-1.03M-8.25M737K-5.69M-6.6M-13.54M1.4M-19.04M-13.49M-27.45M-22.7M-21.09M-14.79M
Pretax Margin %19.82%32.54%39.76%58.99%21.58%26.43%22.46%-2.8%-27.92%2.06%-20.23%-24.55%-51.92%2.73%-84.95%-45.25%-164%-111.23%-97.89%-56.31%
Income Tax3M-245.35M-280K369K65K881K00000000000-60K-136K-970K
Effective Tax Rate %25.76%-1080.18%-1.01%0.62%0.56%5.79%0%0%0%0%0%0%0%0%0%0%0%0.26%0.64%6.56%
Net Income8.65M268.06M27.9M59.61M11.45M14.34M12.42M-1.03M-8.25M737K-5.69M-6.6M-13.54M1.4M-19.04M-13.49M-27.45M-22.64M-20.95M-13.82M
Net Margin %14.71%384.04%40.17%58.63%21.46%24.9%22.46%-2.8%-27.92%2.06%-20.23%-24.55%-51.92%2.73%-84.95%-45.25%-164%-110.94%-97.26%-52.62%
Net Income Growth %-24.39%1769.22%124.62%5887.67%238.79%1845.86%318.22%84.39%39.07%-47.39%70.1%51.08%50.68%106.19%9.14%2.38%-169.48%-17.7%-47.82%21.36%
Net Income (Continuing)8.65M268.06M27.9M59.61M11.45M14.34M12.42M-1.03M-8.25M737K-5.69M-6.6M-13.54M1.4M-19.04M-13.49M-27.45M-22.64M-20.95M-13.82M
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)0.4413.541.463.280.630.800.70-0.06-0.470.04-0.33-0.38-0.800.10-1.10-0.80-1.60-1.30-1.20-0.80
EPS Growth %-30.16%1592.5%108.57%5566.67%234.04%1795.73%312.12%84.21%41.25%-57.8%70%52.5%50%107.69%8.33%0%-172.73%-18.18%-42.86%23.08%
EPS (Basic)0.4714.721.553.330.640.810.71-0.06-0.470.04-0.33-0.38-0.800.10-1.10-0.80-1.60-1.30-1.20-0.80
Diluted Shares Outstanding19.69M18.84M19.16M18.16M18.17M17.99M17.65M17.55M17.52M17.45M17.44M17.36M17.36M17.29M17.28M17.21M17.18M17.11M17.09M17.02M
Basic Shares Outstanding18.41M17.99M18.04M17.89M17.81M17.65M17.6M17.55M17.52M17.45M17.44M17.36M17.36M17.29M17.28M17.21M17.18M17.11M17.09M17.02M
Dividend Payout Ratio--------------------